EAM Investors’s iRadimed IRMD Stock Holding History

EAM Investors’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.81M	Sell	49,995 -5,111	-9%	-$511K	0.56%	58
2025 Q4	$5.36M	Buy	+55,106	New	+$4.73M	0.6%	57
2023 Q4	–	Sell	-20,476	Closed	-$909K	–	311
2023 Q3	$909K	Sell	20,476 -21,092	-51%	-$980K	0.18%	250
2023 Q2	$1.98M	Buy	+41,568	New	+$1.87M	0.37%	107
2022 Q2	–	Sell	-76,179	Closed	-$3.42M	–	293
2022 Q1	$3.42M	Buy	76,179 +29,993	+65%	+$1.39M	0.64%	27
2021 Q4	$2.13M	Sell	46,186 -1,361	-3%	-$54.9K	0.35%	103
2021 Q3	$1.6M	Buy	+47,547	New	+$1.62M	0.27%	184
2019 Q2	–	Sell	-24,263	Closed	-$682K	–	281
2019 Q1	$682K	Sell	24,263 -45,587	-65%	-$1.19M	0.17%	224
2018 Q4	$1.71M	Buy	69,850 +8,643	+14%	+$232K	0.46%	80
2018 Q3	$2.27M	Buy	61,207 +24,433	+66%	+$659K	0.34%	141
2018 Q2	$763K	Buy	36,774 +7,348	+25%	+$130K	0.12%	243
2018 Q1	$415K	Sell	29,426 -715	-2%	-$10.2K	0.07%	280
2017 Q4	$457K	Buy	+30,141	New	+$383K	0.08%	290
2016 Q1	–	Sell	-78,945	Closed	-$2.21M	–	318
2015 Q4	$2.21M	Buy	78,945 +311	+0.4%	+$8.79K	0.29%	159
2015 Q3	$1.92M	Buy	78,634 +529	+0.7%	+$12.7K	0.3%	151
2015 Q2	$1.82M	Buy	+78,105	New	+$1.43M	0.21%	192

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EAM Investors's IRMD Position: Q1 2026 in Review

EAM Investors reduced its iRadimed (IRMD) stake by 9.3% in Q1 2026, selling an estimated $511K and leaving 49,995 shares worth $4.81M. The position accounts for 0.56% of the portfolio, ranked #58.

EAM Investors first reported a position in IRMD in Q2 2015 and has held it in 16 quarters since. The position peaked at $5.36M in Q4 2025. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.

EAM Investors held 49,995 shares of iRadimed worth $4.81M as of Q1 2026.
EAM Investors sold 5,111 iRadimed shares in Q1 2026, an estimated $511K.
iRadimed made up 0.56% of EAM Investors's portfolio in Q1 2026, its #58 holding.
EAM Investors first reported a position in iRadimed in Q2 2015 and has held it in 16 quarters since.
EAM Investors's iRadimed position peaked at $5.36M in Q4 2025.
228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.

Based on EAM Investors's 13F filing for Q1 2026, filed 13 May 2026.